$Plug Power (PLUG.US)$ Oct. 29, 2024, 05:42 AM
In a report released today, Kashy Harrison from Piper Sandler maintained a Sell rating on Plug Power (PLUG – Research Report), with a price target of $1.60. The company’s shares closed yesterday at $2.24.

$Esperion Therapeutics (ESPR.US)$ The recent analyst note from Jeff sugest Esperion might sell the entire rights for Bempedoic Acid. Fair valuation on the rights would be above $1.5 billion, based on future milestones $900 million, future royalties & patents, the current formulation patent has exp date Dec 2031. The potential yearly sales in the U.S could reach $4 billion by 2027.
Esperion could also partner in the U.S .
Keep an...

$Plug Power (PLUG.US)$ currently at $2.12 PLUG is trading below fair value. Book value is $3.79 & Growth ability is tremendous. This energy sector play is must have in the speculative part of your portfolio. Analysts need to get behind this company.